BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 18062768)

  • 1. The biology of interleukin-2.
    Malek TR
    Annu Rev Immunol; 2008; 26():453-79. PubMed ID: 18062768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The main function of IL-2 is to promote the development of T regulatory cells.
    Malek TR
    J Leukoc Biol; 2003 Dec; 74(6):961-5. PubMed ID: 12960253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in health and disease.
    Piccirillo CA
    Cytokine; 2008 Sep; 43(3):395-401. PubMed ID: 18722786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppressor T-cells: immunologic regulator cells and clinical perspectives].
    Neumann-Haefelin C; Spangenberg HC; Thimme R; Blum HE
    Dtsch Med Wochenschr; 2004 Jul; 129(30):1627-30. PubMed ID: 15257502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.
    Pérol L; Piaggio E
    Methods Mol Biol; 2016; 1371():11-28. PubMed ID: 26530792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance, not immunity, crucially depends on IL-2.
    Malek TR; Bayer AL
    Nat Rev Immunol; 2004 Sep; 4(9):665-74. PubMed ID: 15343366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-2/IL-2 receptor system: a target for rational immune intervention.
    Waldmann TA
    Immunol Today; 1993 Jun; 14(6):264-70. PubMed ID: 8397768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.
    Bayer AL; Pugliese A; Malek TR
    Immunol Res; 2013 Dec; 57(1-3):197-209. PubMed ID: 24214027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2)].
    Wustrow TP
    HNO; 1991 Sep; 39(9):323-31. PubMed ID: 1836210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
    Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M
    J Immunol; 1995 Aug; 155(3):1151-64. PubMed ID: 7636184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.
    Waldmann TA
    Nat Rev Immunol; 2006 Aug; 6(8):595-601. PubMed ID: 16868550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the role of IL2 in the interplay between CD4+ helper and regulatory T cells: studying the impact of IL2 modulation therapies.
    García-Martínez K; León K
    Int Immunol; 2012 Jul; 24(7):427-46. PubMed ID: 22371423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.
    Agostini C; Trentin L; Facco M; Sancetta R; Cerutti A; Tassinari C; Cimarosto L; Adami F; Cipriani A; Zambello R; Semenzato G
    J Immunol; 1996 Jul; 157(2):910-8. PubMed ID: 8752945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A; Bastos MG; Muggia RA; Pankewycz O; Nichols J; Murphy JR; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1992 Mar; 22(3):697-702. PubMed ID: 1547815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
    Jackaman C; Nelson DJ
    Cancer Immunol Immunother; 2012 Apr; 61(4):549-60. PubMed ID: 22002241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 and systemic lupus erythematosus--fifteen years later.
    Crispin JC; Alcocer-Varela J
    Lupus; 1998; 7(4):214-22. PubMed ID: 9643310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

  • 20. Defective production of and response to IL-2 in acute human falciparum malaria.
    Ho M; Webster HK; Green B; Looareesuwan S; Kongchareon S; White NJ
    J Immunol; 1988 Oct; 141(8):2755-9. PubMed ID: 2971729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.